Strategies to decrease pertussis transmission to infants
K Forsyth, S Plotkin, T Tan, CH Wirsing von König - Pediatrics, 2015 - publications.aap.org
The Global Pertussis Initiative (GPI) is an expert scientific forum addressing the worldwide
burden of pertussis, which remains a serious health issue, especially in infants. This age …
burden of pertussis, which remains a serious health issue, especially in infants. This age …
[HTML][HTML] Interventions to increase vaccination against COVID-19, influenza and pertussis during pregnancy: a systematic review and meta-analysis
Background Pregnant women and their babies face significant risks from three vaccine-
preventable diseases: COVID-19, influenza, and pertussis. However, despite these …
preventable diseases: COVID-19, influenza, and pertussis. However, despite these …
A cytokine-independent approach to identify antigen-specific human germinal center T follicular helper cells and rare antigen-specific CD4+ T cells in blood
JM Dan, CS Lindestam Arlehamn… - The Journal of …, 2016 - journals.aai.org
Detection of Ag-specific CD4+ T cells is central to the study of many human infectious
diseases, vaccines, and autoimmune diseases. However, such cells are generally rare and …
diseases, vaccines, and autoimmune diseases. However, such cells are generally rare and …
Waning Tdap effectiveness in adolescents
NP Klein, J Bartlett, B Fireman, R Baxter - Pediatrics, 2016 - publications.aap.org
METHODS: We modeled pertussis risk in relation to Tdap vaccination status among
adolescents beginning on their 10th birthday. We estimated the hazard ratio (HR) for each …
adolescents beginning on their 10th birthday. We estimated the hazard ratio (HR) for each …
What is wrong with pertussis vaccine immunity? The problem of waning effectiveness of pertussis vaccines
N Burdin, LK Handy, SA Plotkin - Cold Spring Harbor …, 2017 - cshperspectives.cshlp.org
Pertussis is resurgent in some countries, particularly those in which children receive
acellular pertussis (aP) vaccines in early infancy and boosters later in life. Immunologic …
acellular pertussis (aP) vaccines in early infancy and boosters later in life. Immunologic …
Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology
SL Sheridan, K Frith, TL Snelling… - Expert review of …, 2014 - Taylor & Francis
The recent epidemics of pertussis (whooping cough) in parts of the USA and Australia have
led to the largest numbers of annual cases reported in over half a century. These epidemics …
led to the largest numbers of annual cases reported in over half a century. These epidemics …
Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model
Whooping cough or pertussis is a highly infectious respiratory disease in humans caused by
Bordetella pertussis. The use of acellular vaccines (ACV) has been associated with the …
Bordetella pertussis. The use of acellular vaccines (ACV) has been associated with the …
Predictors of disease severity in children hospitalized for pertussis during an epidemic
H Marshall, M Clarke, K Rasiah… - The Pediatric …, 2015 - journals.lww.com
Background: Australia recently experienced its worst pertussis epidemic since introduction
of pertussis vaccine into the National Immunisation Program. This study aimed to determine …
of pertussis vaccine into the National Immunisation Program. This study aimed to determine …
Acellular pertussis vaccine effectiveness over time
OBJECTIVES: To determine pertussis risk by diphtheria-tetanus-acellular pertussis (DTaP)
vaccination status and time since last DTaP dose. METHODS: Children born at Kaiser …
vaccination status and time since last DTaP dose. METHODS: Children born at Kaiser …
Licensed pertussis vaccines in the United States: history and current state
NP Klein - Human vaccines & immunotherapeutics, 2014 - Taylor & Francis
The United States switched from whole cell to acellular pertussis vaccines in the 1990s
following global concerns with the safety of the whole cell vaccines. Despite high levels of …
following global concerns with the safety of the whole cell vaccines. Despite high levels of …